World Psychiatry Journal 02/2015: Multicenter double blinded randomized controlled trial results show Brainsway Deep TMS to be efficacious and safe for drug-resistant depression, with a stable effect over 3 months of maintenance treatment.

A clinically significant improvement was seen even  in highly treatment-resistant patients who did not respond to three or more antidepressant medications in the current episode

This multicenter study examined Brainsway® Deep TMS (Transcranial Magnetic Stimulation) as a treatment for major depressive disorder. The study included over 200 patients who were randomly assigned for real or sham Deep TMS (20 sessions) over a period of a month. Thereafter, patients underwent a maintenance period that included additional two sessions/week over three months.  The study found that the real Deep Transcranial Magnetic Stimulation treatment was superior to the sham treatment and induced a beneficial effect that was evident after both the acute phase and the maintenance phase. The results indicate that Brainsway Deep TMS is effective and safe as a treatment for major depressive disorder.

View publication